arrow
返回
J

Jan Oscarsson

astrazeneca

47H指数
210论文数
8.7K被引数
收录论文 71
发表时间
A machine learning approach to non-invasive prediction of hepatic decompensation in compensated advanced chronic liver disease: the CIRI model机器学习方法预测代偿期晚期慢性肝病肝功能失代偿:CIRI模型
err2026-07-16
err0
errOAAI
errGeorg Kramer; Anders Hildeman; Caterina Tozzi; Roza Maghsood; Vinusha Kalatharan; Hyewon Nina Koo; Kinga Jastrzębska; Nils Svangård; Claire Donoghue; Benedikt Simbrunner; Benedikt Silvester Hofer; Mattias Mandorfer; Thomas Reiberger; Jan Oscarsson; Philip Ambery
err分享
err收藏
Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis达格列净对伴有肝纤维化风险的2型糖尿病患者心血管结局的影响
err2026-04-27
err0
errOAAI
errJan Oscarsson; Monika Huhn; Yunyun Jiang; Ingrid Gause-Nilsson; Stephen D. Wiviott; Filipe A. Moura; John P. H. Wilding; Simona Cernea; Luc Van Gaal; Avivit Cahn; Deepak L. Bhatt; Peter A. Johansson; C. David Sjöström
err分享
err收藏
Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory studyzibotentan和dapagliflozin联合治疗代偿期肝硬化患者的效果:一项随机、安慰剂对照的探索性研究
err2025-12-01
err0
PREAI
errGarcia-Pagan, Juan Carlos; Gluud, Lise Lotte; Mandorfer, Mattias; Schattenberg, Jorn M.; De Gottardi, Andrea; Berzigotti, Annalisa; Fortea, Jose Ignacio; Martinez, Agustin Albillos; Alvarado-Tapias, Edilmar; Berning, Marco; Petryszyn, Pawel; Henricson, Emilia; Berglind, Niklas; Lin, Min; Persson, Kevin; Mercier, Anne-kristina; Ambery, Phil; Bosch, Jaime; Oscarsson, Jan; Rockey, Don C.
err分享
err收藏
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study
err2024-06-28
err0
errOAAI
errLatva-Rasku, Aino; Rebelos, Eleni; Tuisku, Jouni; Aarnio, Richard; Bhowmik, Achol; Keskinen, Helmi; Laurila, Sanna; Lahesmaa-Hatting, Minna; Pekkarinen, Laura; Isackson, Henrik; Kirjavainen, Anna K.; Koffert, Jukka; Heurling, Kerstin; Nummenmaa, Lauri; Ferrannini, Ele; Oldgren, Jonas; Oscarsson, Jan; Nuutila, Pirjo
err分享
err收藏
Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo-Insights from DECLARE-TIMI 58
err2024-06-14
err0
PREAI
errKang, Yu Mi; Melloni, Giorgio E. M.; Cahn, Avivit; Raz, Itamar; Moura, Filipe; Bhatt, Deepak L.; Inzucchi, Silvio E.; Leiter, Lawrence A.; McGuire, Darren K.; Wilding, John; Gause-Nilsson, Ingrid A.; Oscarsson, Jan; Marston, Nicholas; Ruff, Christian T.; Sabatine, Marc S.; Wiviott, Stephen D.
err分享
err收藏
Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58
err2024-06-14
err0
PREAI
errKang, Yu Mi; Melloni, Giorgio E. M.; Cahn, Avivit; Raz, Itamar; Moura, Filipe; Bhatt, Deepak L.; Inzucchi, Silvio E.; Leiter, Lawrence A.; McGuire, Darren K.; Wilding, John; Gause-Nilsson, Ingrid A.; Oscarsson, Jan; Marston, Nicholas; Ruff, Christian T.; Sabatine, Marc S.; Wiviott, Stephen D.
err分享
err收藏
Targeting the endothelium by combining endothelin-1 antagonism and SGLT-2 inhibition: better together?
err2024-06-05
err0
errOAAI
errAmbery, Phil; Greasley, Peter J.; Menzies, Robert I.; Brynne, Lena; Kulkarni, Spoorthy; Oscarsson, Jan; Davenport, Anthony P.
err分享
err收藏
A comprehensive analysis of liver safety across zibotentan oncology trials: knowledge of the past offers new perspectives on the present
err2024-03-24
err1
errOAAI
errFettiplace, Anna; Matis-Mitchell, Sherri; Molodetskyi, Oleksandr; Soderbergh, Malin; Oscarsson, Jan; Lin, Min; Ravikiran, Srivathsa; Billger, Martin; Ambery, Philip
err分享
err收藏
A qualitative patient interview study to understand the experience of patients with nonalcoholic steatohepatitis
err2023-03-01
err3
errOAAI
errSwain, Mark G.; Pettersson, Billie; Meyers, Oren; Venerus, Meredith; Oscarsson, Jan
err分享
err收藏
Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on substrate metabolism in prediabetic insulin resistant individuals: A randomized, double-blind crossover trial
err2023-03-01
err16
PREAI
errVeelen, Anna; Andriessen, Charlotte; den Kamp, Yvo Op; Erazo-Tapia, Edmundo; de Ligt, Marlies; Mevenkamp, Julian; Jorgensen, Johanna A.; Moonen-Kornips, Esther; Schaart, Gert; Esterline, Russell; Havekes, Bas; Oscarsson, Jan; Schrauwen-Hinderling, Vera B.; Phielix, Esther; Schrauwen, Patrick
err分享
err收藏
Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism
err2022-12-01
err22
errOAAI
errop den Kamp, Yvo J. M.; Gemmink, Anne; de Ligt, Marlies; Dautzenberg, Bas; Kornips, Esther; Jorgensen, Johanna A.; Schaart, Gert; Esterline, Russell; Pava, Diego A.; Hoeks, Joris; Schrauwen-Hinderling, Vera B.; Kersten, Sander; Havekes, Bas; Koves, Timothy R.; Muoio, Deborah M.; Hesselink, Matthijs K. C.; Oscarsson, Jan; Phielix, Esther; Schrauwen, Patrick
err分享
err收藏
Erratum. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care (vol 44,pg 1433-1442, 2022)
err2022-10-13
err1
errOAAI
errNahra, Rajaa; Wang, Tao; Gadde, Kishore M.; Oscarsson, Jan; Stumvoll, Michael; Jermutus, Lutz; Hirshberg, Boaz; Ambery, Philip
err分享
err收藏
Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH肝细胞的细胞衰老有助于NASH的代谢紊乱
err2022-08-22
err14
errOAAI
errBonnet, Laurianne; Alexandersson, Ida; Baboota, Ritesh K. K.; Kroon, Tobias; Oscarsson, Jan; Smith, Ulf; Boucher, Jeremie
err分享
err收藏
Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial (vol 44, pg 1334, 2021)
err2022-03-03
err0
errOAAI
errden Kamp, Yvo J. M. Op; de Ligt, Marlies; Dautzenberg, Bas; Kornips, Esther; Esterline, Russell; Hesselink, Matthijs K. C.; Hoeks, Joris; Schrauwen-Hinderling, Vera B.; Havekes, Bas; Oscarsson, Jan; Phielix, Esther; Schrauwen, Patrick
err分享
err收藏
Omega-3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non-alcoholic fatty liver disease
err2021-10-07
err18
PREAI
errCamacho-Munoz, Dolores; Kiezel-Tsugunova, Magdalena; Kiss, Orsolya; Uddin, Mohib; Sunden, Mattias; Ryaboshapkina, Maria; Lind, Lars; Oscarsson, Jan; Nicolaou, Anna
err分享
err收藏
Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial
err2021-04-15
err32
errOAAI
errOp den Kamp, Yvo J. M.; de Ligt, Marlies; Dautzenberg, Bas; Kornips, Esther; Esterline, Russell; Hesselink, Matthijs K. C.; Hoeks, Joris; Schrauwen-Hinderling, Vera B.; Havekes, Bas; Oscarsson, Jan; Phielix, Esther; Schrauwen, Patrick
err分享
err收藏
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study钠-葡萄糖co-transporter-2抑制剂达格列净治疗6周对2型糖尿病患者心肌功能和代谢的影响: 一项随机、安慰剂对照、探索性研究
err2021-03-12
err47
PREAI
errOldgren, Jonas; Laurila, Sanna; Akerblom, Axel; Latva-Rasku, Aino; Rebelos, Eleni; Isackson, Henrik; Saarenhovi, Maria; Eriksson, Olof; Heurling, Kerstin; Johansson, Edvin; Wilderang, Ulrica; Karlsson, Cecilia; Esterline, Russell; Ferrannini, Ele; Oscarsson, Jan; Nuutila, Pirjo
err分享
err收藏
The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat
err2020-10-30
err11
errOAAI
errLind, Lars; Salihovic, Samira; Riserus, Ulf; Kullberg, Joel; Johansson, Lars; Ahlstrom, Hakan; Eriksson, Jan W.; Oscarsson, Jan
err分享
err收藏